The previous page is sending you to https://www.prnewswire.com/news-releases/allergan-and-adamas-announce-new-expanded-indication-for-namzaric-memantine-and-donepezil-hydrochlorides-extended-release-for-the-treatment-of-moderate-to-severe-alzheimers-disease-300300474.html.

 If you do not want to visit that page, you can return to the previous page.